Navigating Evolving mRNA Challenges with the Right Partner
The market for mRNA vaccines has experienced a surge fueled by the global rollout of the COVID-19 vaccines, and the potential of mRNA technology in public health opens a new frontier in medical science....
Gamida Cell to Present at the BTIG Virtual Biotechnology Conference – Business Wire
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will participate in a fireside chat at the...
Webinars with patients-survey: 73% with chronic illnesses feel more COVID-19 risk
Ongoing series of surveys of 1,300 patients is tracking changing concerns over two weeks as pandemic continues
Credit: Health Perspectives Group
70% have concerns that COVID-19 will hurt...
MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update – Business...
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for the second quarter ended June 30, 2022, and provided a...
Scientists uncover simple strategies for keeping foams on walls
Tokyo, Japan – Researchers from Tokyo Metropolitan University have uncovered a unique mechanism by which foams on walls drain and slip over time. They showed how a foam can lose liquid via “pinch-off”, like...
“Effective dsRNAs” Combat Cucumber Mosaic Virus in Tests
Researchers at the Martin Luther University Halle-Wittenberg (MLU) have developed RNA-based active agents that appear to reliably protect plants against cucumber mosaic virus (CMV), the most common virus in agriculture and horticulture. Developed to...
StockWatch: HHS Review of Bird Flu Contract Sinks Moderna Shares
Moderna (NASDAQ: MRNA) shares have tumbled 31% since January 28, capped by a 7% decline Thursday and a 2% dip Friday in the messenger RNA (mRNA) vaccine developer’s stock following a news report that...
Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS
Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of its small molecule candidate drug in Huntington’s disease and amyotrophic lateral sclerosis, incurable conditions that have very limited treatment...
Thermo Fisher to Expand Coronavirus, Infectious Disease Dx with Planned $11.5B QIAGEN Acquisition
Marc N. Casper, Thermo Fisher Scientific chairman, president, and CEO
Thermo Fisher Scientific has signaled its intent to expand its molecular diagnostics portfolio with a new SARS-CoV-2 coronavirus test under evaluation in China and other...
AI may help identify potential gonorrhea vaccine proteins
Gonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics. That makes it notoriously difficult to treat, but left untreated,...
